Ontario Teachers Pension Plan Board Has $155.80 Million Stock Position in Humana Inc. (NYSE:HUM)

Ontario Teachers Pension Plan Board cut its stake in shares of Humana Inc. (NYSE:HUM) by 47.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 614,079 shares of the insurance provider’s stock after selling 559,456 shares during the quarter. Humana accounts for about 1.9% of Ontario Teachers Pension Plan Board’s portfolio, making the stock its 17th largest position. Ontario Teachers Pension Plan Board’s holdings in Humana were worth $155,798,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the company. Transcend Capital Advisors LLC lifted its holdings in Humana by 399.7% during the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock worth $924,000 after buying an additional 2,914 shares during the period. FNY Investment Advisers LLC increased its position in Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after purchasing an additional 26,856 shares during the period. Retirement Systems of Alabama raised its holdings in Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after purchasing an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Humana by 7.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock worth $244,811,000 after purchasing an additional 65,735 shares during the period. Finally, Secure Asset Management LLC bought a new stake in shares of Humana in the 4th quarter valued at $244,000. 92.38% of the stock is currently owned by institutional investors.

Humana Trading Down 3.7 %

Shares of HUM stock opened at $284.27 on Tuesday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $34.31 billion, a P/E ratio of 28.57, a PEG ratio of 2.05 and a beta of 0.62. The company has a 50 day moving average of $265.43 and a 200-day moving average of $270.11. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.25%. Humana’s dividend payout ratio is presently 35.58%.

Analysts Set New Price Targets

Several research firms recently issued reports on HUM. Guggenheim started coverage on shares of Humana in a report on Wednesday, April 9th. They issued a “buy” rating and a $326.00 target price on the stock. Barclays raised their target price on Humana from $270.00 to $322.00 and gave the stock an “equal weight” rating in a research note on Friday. Royal Bank of Canada restated an “outperform” rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. StockNews.com upgraded shares of Humana from a “hold” rating to a “buy” rating in a research note on Monday, April 7th. Finally, Morgan Stanley cut their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Seventeen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $288.60.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.